It is, therefore, evident that a significant degree of molecular conservation exists between SMA and ALS and that a greater identification and characterisation of these commonly dysregulated cascades may prove therapeutically beneficial. The gene discussed is SMN1; the disease is amyotrophic lateral sclerosis.